Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sunshine rising soon: Making ready for financial relationship reporting

This article was originally published in Scrip

Executive Summary

While the Obama administration has been postponing certain provisions of the Affordable Care Act in recent weeks, it appears all systems are go for the measure requiring biopharmaceutical and device makers whose products are covered by Medicare, Medicaid and the Children's Health Insurance Program to report their financial relationships with doctors and teaching hospitals to the federal government – information that will be made publicly available under the Physician Payment Sunshine Act.

Latest Headlines
See All
UsernamePublicRestriction

Register

SC022103

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel